The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].
Reply to Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211 / A. Casiraghi, C.G.M. Gennari, U.M. Musazzi, M.A. Ortenzi, S. Bordignon, P. Minghetti. - In: PHARMACEUTICS. - ISSN 1999-4923. - 12:9(2020 Aug 28).
Reply to Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211
A. Casiraghi
Primo
Writing – Original Draft Preparation
;C.G.M. GennariSecondo
;U.M. Musazzi;M.A. Ortenzi;S. Bordignon;P. MinghettiUltimo
Writing – Review & Editing
2020
Abstract
The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
pharmaceutics-Reply Zur.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
342.64 kB
Formato
Adobe PDF
|
342.64 kB | Adobe PDF | Visualizza/Apri |
|
pharmaceutics-12-00822.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
170.56 kB
Formato
Adobe PDF
|
170.56 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
